MedPath

Nonoperative Management Protocol in Patients With Blunt Splenic Injuries

Completed
Conditions
Blunt Injuries
Interventions
Other: Patient before cohort (2005-2010)
Other: Patient after cohort (2011-2016)
Registration Number
NCT03943355
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period in our institution.

Detailed Description

The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
399
Inclusion Criteria
  • Adult trauma patients with blunt splenic injury who were admitted from 2005 to 2016.
Exclusion Criteria
  • Patients younger than 16 years
  • Patients who died in the emergency department

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Nonoperative management protocol with angioembolizationPatient after cohort (2011-2016)The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
Nonoperative management protocol with angioembolizationPatient before cohort (2005-2010)The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
Primary Outcome Measures
NameTimeMethod
The numbers of associated complications and mortalityup to 6 months

The primary outcome of interest in this study would be the associated complications and mortality.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath